Global Communications

test title

October 02, 2014

West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland

Expands global capabilities to meet customer demand

On October 2, 2014, Ireland’s Prime Minister Enda Kenny, and Richard Bruton, Minister for Jobs, Enterprise & Innovation for Ireland, joined West Chairman and CEO Don Morel to announce that West plans to expand its global manufacturing operations to include a new site in Waterford, Ireland. The event was held at Tower Hotel, The Mall, Waterford.

The new facility will produce packaging components for insulin injector cartridges and other high value packaging components, in order to meet growing demand from pharmaceutical and biotech customers. Once operational, this new site could bring approximately 150 new jobs to Waterford and is intended to grow to support additional jobs through expansions in the future.

“With diabetes emerging as one of the fastest growing diseases globally, our pharmaceutical customers are expanding their production lines for injectable insulin. To meet this growing demand, we are announcing an expansion today that will help us address this need and continue to serve this critical patient population,” said Donald E. Morel, Jr., West’s Chairman and Chief Executive Officer. “In the future, we intend for this site to be a center of excellence for advanced packaging components to meet the future needs of our customer base for a range of sophisticated injectable therapies.”

“Waterford, Ireland, is an ideal setting for this new plant, given its business-friendly environment and the growing health science industry in the area,” Morel added. “On behalf of West’s Board of Directors, I would like to thank the many representatives of Waterford City, the Irish Government and the Irish Development Agency for their support.”

 

An Taoiseach Enda Kenny TD said, “I am delighted with this announcement of a new manufacturing facility in the South East by West Pharmaceutical Services which will create 100 construction jobs during its development and an initial 150 new jobs when operational. It is a massive boost for Waterford and the entire South East and I am happy that Government was able to assist through the work of the IDA. The Government is determined to secure economic recovery by incentivizing job creation and further investment in the area.  Today’s announcement continues our strong track record on attracting employers in the medical devices sector and we will continue to prioritize Government support for sectors with real growth potential through our Action Plan for Jobs.”

Construction is planned to begin in early 2015 on the 44-acre site at Knockhouse on Old Kilmeaden Road in Waterford, subject to the project obtaining requisite planning and zoning approvals, which the Company believes will occur later this year. This site will be a center of excellence for our proprietary elastomeric sheeting , which is used to package insulin for use in pen injectors. Future plans include additional manufacturing space for West’s proprietary injectable component product lines, which are integral to many injectable and dosage forms. With these planned expansions, the plant eventually could accommodate between 250 to 300 jobs total.

West has maintained a presence in Ireland since 2005 with a manufacturing and development center in Dublin, which is the European headquarters for The Tech Group, a West subsidiary that specializes in providing device design, development and manufacturing services for pharmaceutical and med-tech customers. Employing over 230 people at its Mulhuddart, Dublin facility, it is also undergoing an expansion as a result of securing a number of significant customer programs.